COMBODY: one-domain antibody multimer with improved avidity (Q83155862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

COMBODY: one-domain antibody multimer with improved avidity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Xuekai Zhu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lei Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Rongzhi Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Barry Flutter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shenghua Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jie Ding

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hua Tao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Changzhen Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Meiyi Sun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bin Gao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

9 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

667-675

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

Potent antibody therapeutics by design

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Development trends for monoclonal antibody cancer therapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

The pharmacology of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Recombinant antibody fragments

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Localization of antibody-combining sites within the variable portions of heavy and light chains

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Escherichia coli secretion of an active chimeric antibody fragment.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Engineered human antibody constant domains with increased stability

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Single-domain antibody fragments with high conformational stability

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Prokaryotic expression of antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Efficient tumor targeting by single-domain antibody fragments of camels

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Properties, production, and applications of camelid single-domain antibody fragments

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

The assembly of single domain antibodies into bispecific decavalent molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Alpha-helical coiled coils and bundles: how to design an alpha-helical protein

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Alpha-helical coiled-coil oligomerization domains in extracellular proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Alpha-helical protein assembly motifs

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Coiled coils: new structures and new functions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

A pentavalent single-domain antibody approach to tumor antigen discovery and the development of novel proteomics reagents

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Efficient cancer therapy with a nanobody-based conjugate

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

"Peptabody": a new type of high avidity binding protein

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Development of a bispecific F(ab')2 conjugate against the complement receptor CR3 of macrophages and a variant CD44 antigen of rat pancreatic adenocarcinoma for redirecting macrophage-mediated tumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Two-step total gene synthesis method

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.21

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20212511%20AND%20SRC:MED&resulttype=core&format=json